tiprankstipranks
Lyra Therapeutics, Inc. (LYRA)
OTHER OTC:LYRA
US Market
LYRA
Lyra Therapeutics
RESEARCH TOOLSreports

Lyra Therapeutics (LYRA) Income Statement

363 Followers

Lyra Therapeutics Income Statement

Last quarter (Q4 2025), Lyra Therapeutics's total revenue was $7.00K, a decrease of -96.65% from the same quarter last year. In Q4, Lyra Therapeutics's net income was $-6.95M. See Lyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 398.00K$ 1.53M$ 1.56M$ 1.36M$ 285.00K
Gross Profit
$ 0.00$ 1.53M$ 1.56M$ 1.36M$ -29.41M
Operating Expenses
$ 31.42M$ 97.88M$ 68.68M$ 57.67M$ 14.21M
Depreciation and Amortization
$ 0.00$ 471.00K$ 278.00K$ 1.07M$ 1.00M
EBITDA
$ -31.02M$ -60.26M$ -65.25M$ -53.92M$ -42.61M
Operating Income
$ -31.02M$ -96.35M$ -67.12M$ -56.31M$ -43.62M
Other Income/Expenses
$ 2.11M$ 2.95M$ 4.50M$ 1.04M$ 102.00K
Pretax Income
$ -28.91M$ -93.40M$ -62.62M$ -55.27M$ -43.51M
Net Income
$ -28.92M$ -93.44M$ -62.68M$ -55.28M$ -43.51M
Per Share Metrics
Basic EPS
$ -18.62$ -1.43$ -1.26$ -1.83$ -3.35
Diluted EPS
$ -18.62$ -1.43$ -1.26$ -1.83$ -3.35
Weighted Average Shares Outstanding
 15.53M 65.11M 49.75M 30.24M 12.99M
Weighted Average Shares Outstanding (Diluted)
 15.53M 65.11M 49.80M 30.24M 12.99M
Currency in USD

Lyra Therapeutics Earnings and Revenue History